In contrast to CD30 CAR-T recipients who infrequently received corticosteroids, 6 (66.7%) CD19 CAR-T patients received corticosteroids before infection, consistent with published data [9, 11, 13, 21, 22]. This evidence concerns the gene CD19 and infection.